FDA warns doctors of counterfeit Botox

Published on NewsOK Modified: December 24, 2012 at 7:54 am •  Published: December 24, 2012
Advertisement
;

WASHINGTON (AP) — Federal regulators have warned more than 350 medical practices that Botox they may have received from a Canadian supplier is unapproved and could be counterfeit or unsafe.

The Food and Drug Administration said in a letter sent last month, a letter released publicly last week, that batches of the wrinkle treatment shipped by suppliers owned by pharmacy Canada Drugs have not been approved by the FDA and that the agency cannot assure their effectiveness or their safety.

The FDA said Canada Drugs was previously tied to shipping unapproved and counterfeit cancer drugs.

The agency warned doctors about buying drugs from sources other than licensed U.S. pharmacies. It is the fifth warning the agency has made this year about foreign suppliers providing unapproved drugs.

In February, the agency warned 19 medical practices that they had received a counterfeit version of the cancer drug Avastin. On three more occasions the FDA issued similar warnings about counterfeit Avastin and Altuzan, another brand name for the same drug. The alerts were also primarily targeted at drugs distributed by Canada Drugs.



Trending Now


AROUND THE WEB

  1. 1
    Oklahoma City Thunder: Kevin Durant reportedly trying to get Caron Butler to return
  2. 2
    Isolated Amazon Tribe Makes First Contact
  3. 3
    911 Dispatcher Handles Call About Her Choking Son
  4. 4
    Cops: Woman Faked Drowning to Avoid Court
  5. 5
    Brazilians Listened to the Song ‘Happy’ a Lot More After Their World Cup Disaster Against...
+ show more